Hepatocellular carcinoma (HCC) is the most common type of primary hepatic cancer and is
among the major causes of mortality due to cancer. Due to the lack of efficient conventional …

Metastasis accounts for greater than 90% of cancer-related deaths. Despite recent
advancements in conventional chemotherapy, immunotherapy, targeted therapy, and their …

Hepatocellular carcinoma (HCC) is the second most common cause of cancer-related
deaths in the world. More than half of patients with HCC present with advanced stage, and …

Non-alcoholic fatty liver disease (NAFLD) is a highly prevalent and slow progressing hepatic
pathology characterized by different stages of increasing severity which can ultimately give …

The purpose of this study was to explore the effectiveness of radiomics based on
multisequence MRI in predicting the expression of PD-1/PD-L1 in hepatocellular carcinoma …

Accumulating evidence has confirmed the links between transfer RNA (tRNA) modifications
and tumor progression. The present study is the first to explore the role of tRNA …

The prognostic value of immune cells in tertiary lymphoid structures (TLSs) remains unclear
in hepatocellular carcinoma (HCC). Here, 59 of 145 patients had TLSs in training set, 48 of …

Recently, N 6-methyladenosine (m6A) RNA methylation in eukaryotic mRNA has become
increasingly obvious in the pathogenesis and prognosis of cancer. Moreover, tumor …

Simple Summary Clinical and molecular advances have improved knowledge and treatment
prospects for cancer, yet hepatocellular carcinoma (HCC), the most common form of liver …

Simple Summary Immune checkpoint inhibitors (ICIs) had been explored extensively in
patients affected by unresectable hepatocellular carcinoma. These agents were expected to …